Measuring Visceral Adipose Tissue Metabolic Activity in Sleep Apnea Utilizing Hybrid ¹⁸F-FDG PET/MRI: A Pilot Study

References

• Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014. doi:10.1093/aje/kws342
   PubMed Web of Science ®Google Scholar
• Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310–318. doi:10.1016/S2213-2600(15)00043-0
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384. doi:10.1056/NEJM200005113421901
   PubMed Web of Science ®Google Scholar
• O’Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159–1164. doi:10.1164/rccm.200712-1809OC
   PubMed Web of Science ®Google Scholar
• Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–2176. doi:10.1001/jama.2012.3418
   PubMed Web of Science ®Google Scholar
• Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173(8):910–916. doi:10.1164/rccm.200509-1442OC
   PubMed Web of Science ®Google Scholar
• Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305. doi:10.1016/j.jacc.2013.03.052
   PubMed Web of Science ®Google Scholar
• Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 2011;140(2):534–542. doi:10.1378/chest.10-2223
   PubMed Web of Science ®Google Scholar
• Kylintireas I, Craig S, Nethononda R, et al. Atherosclerosis and arterial stiffness in obstructive sleep apnea–a cardiovascular magnetic resonance study. Atherosclerosis. 2012;222(2):483–489. doi:10.1016/j.atherosclerosis.2012.03.036
   Web of Science ®Google Scholar
• Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034–2041. doi:10.1056/NEJMoa043104
   PubMed Web of Science ®Google Scholar
• Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005;99(4):1592–1599. doi:10.1152/japplphysiol.00587.2005
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235. doi:10.1056/NEJM199304293281704
   PubMed Web of Science ®Google Scholar
• Stadler DL, McEvoy RD, Sprecher KE, et al. Abdominal compression increases upper airway collapsibility during sleep in obese male obstructive sleep apnea patients. Sleep. 2009;32(12):1579–1587. doi:10.1093/sleep/32.12.1579
   PubMed Web of Science ®Google Scholar
• Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343–368. doi:10.1586/14779072.6.3.343
   PubMedGoogle Scholar
• Neeland IJ, Ayers CR, Rohatgi AK, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21(9):E439–447. doi:10.1002/oby.20135
   PubMed Web of Science ®Google Scholar
• McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis. 2014;18(1):41–58. doi:10.1016/j.cld.2013.09.012
   PubMed Web of Science ®Google Scholar
• Elffers TW, de Mutsert R, Lamb HJ, et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS One. 2017;12(9):e0185403. doi:10.1371/journal.pone.0185403
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/CIRCULATIONAHA.106.675355
   PubMed Web of Science ®Google Scholar
• Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the Mesa Study. JACC Cardiovasc Imaging. 2014;7(12):1221–1235. doi:10.1016/j.jcmg.2014.07.017
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ross R, Despres JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725. doi:10.1016/S2213-8587(19)30084-1
   PubMed Web of Science ®Google Scholar
• Bagyura Z, Kiss L, Lux A, et al. Association between coronary atherosclerosis and visceral adiposity index. Nutr Metab Cardiovasc Dis. 2020;30(5):796–803. doi:10.1016/j.numecd.2020.01.013
   PubMed Web of Science ®Google Scholar
• Randrianarisoa E, Lehn-Stefan A, Hieronimus A, et al. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus. J Atheroscler Thromb. 2019;26(9):821–834. doi:10.5551/jat.47274
   Web of Science ®Google Scholar
• Figueroa AL, Takx RA, MacNabb MH, et al. Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events. Circ Cardiovasc Imaging. 2016;9(4):e004043. doi:10.1161/CIRCIMAGING.115.004043
   Web of Science ®Google Scholar
• Neeland IJ, Poirier P, Despres JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391–1406. doi:10.1161/CIRCULATIONAHA.117.029617
   PubMed Web of Science ®Google Scholar
• Gaines J, Vgontzas AN, Fernandez-Mendoza J, Bixler EO. Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev. 2018;42:211–219. doi:10.1016/j.smrv.2018.08.009
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887. doi:10.1038/nature05488
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151–1158. doi:10.1210/jcem.85.3.6484
   PubMed Web of Science ®Google Scholar
• Kritikou I, Basta M, Tappouni R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J. 2013;41(3):601–609. doi:10.1183/09031936.00183411
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008;38(8):585–595. doi:10.1111/j.1365-2362.2008.01984.x
   PubMed Web of Science ®Google Scholar
• Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab. 2005;90(4):2282–2289. doi:10.1210/jc.2004-1696
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–1808. doi:10.1172/JCI200319246
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112(12):1785–1788. doi:10.1172/JCI20514
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830. doi:10.1172/JCI200319451
   PubMed Web of Science ®Google Scholar
• Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25(5):1357–1368. doi:10.1148/rg.255045122
   PubMed Web of Science ®Google Scholar
• Pahk K, Kim EJ, Joung C, Seo HS, Kim S. Association of glucose uptake of visceral fat and acute myocardial infarction: a pilot (18) F-FDGPET/CT study. Cardiovasc Diabetol. 2020;19(1):145. doi:10.1186/s12933-020-01115-3
   Web of Science ®Google Scholar
• Im HJ, Paeng JC, Cheon GJ, et al. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation. Nucl Med Commun. 2016;37(6):616–622. doi:10.1097/MNM.0000000000000488
   Web of Science ®Google Scholar
• Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
   PubMed Web of Science ®Google Scholar
• Martínez-González MA, Fernández-Jarne E, Serrano-Martínez M, Wright M, Gomez-Gracia E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr. 2004;58(11):1550–1552. doi:10.1038/sj.ejcn.1602004
   Web of Science ®Google Scholar
• Pillar G, Berall M, Berry R, et al. Detecting central sleep apnea in adult patients using WatchPAT-a multicenter validation study. Sleep Breath. 2020;24(1):387–398. doi:10.1007/s11325-019-01904-5
   PubMed Web of Science ®Google Scholar
• Bar A, Pillar G, Dvir I, Sheffy J, Schnall RP, Lavie P. Evaluation of a portable device based on peripheral arterial tone for unattended home sleep studies. Chest. 2003;123(3):695–703. doi:10.1378/chest.123.3.695
   PubMed Web of Science ®Google Scholar
• Pittman SD, Ayas NT, MacDonald MM, Malhotra A, Fogel RB, White DP. Using a wrist-worn device based on peripheral arterial tonometry to diagnose obstructive sleep apnea: in-laboratory and ambulatory validation. Sleep. 2004;27(5):923–933. doi:10.1093/sleep/27.5.923
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim EJ, Kim YS, et al. Validation study of portable device for the diagnosis of obstructive sleep apnea according to the new AASM scoring criteria: watch-PAT 100. Acta Otolaryngol. 2010;130(7):838–843. doi:10.3109/00016480903431139
   PubMed Web of Science ®Google Scholar
• Berry RB, Brooks R, Gamaldo C, et al. AASM Scoring Manual Updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665–666. doi:10.5664/jcsm.6576
   PubMed Web of Science ®Google Scholar
• Naik S, Al-Halawani M, Kreinin I, Kryger M. Centers for medicare and medicaid services positive airway pressure adherence criteria may limit treatment to many medicare beneficiaries. J Clin Sleep Med. 2019;15(2):245–251. doi:10.5664/jcsm.7626
   Web of Science ®Google Scholar
• Maislin G, Ahmed MM, Gooneratne N, et al. Single slice vs. volumetric MR assessment of visceral adipose tissue: reliability and validity among the overweight and obese. Obesity. 2012;20(10):2124–2132. doi:10.1038/oby.2012.53
   Web of Science ®Google Scholar
• Poonawalla AH, Sjoberg BP, Rehm JL, et al. Adipose tissue MRI for quantitative measurement of central obesity. J Magn Reson Imaging. 2013;37(3):707–716. doi:10.1002/jmri.23846
   Web of Science ®Google Scholar
• Sivam S, Phillips CL, Trenell MI, et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J. 2012;40(4):913–918. doi:10.1183/09031936.00177011
   Web of Science ®Google Scholar
• Han SH, Sakuma I, Shin EK, Koh KK. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009;52(2):126–140. doi:10.1016/j.pcad.2009.06.004
   Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68(11):975–981. doi:10.1253/circj.68.975
   PubMed Web of Science ®Google Scholar
• Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–188. doi:10.1001/jama.2009.976
   PubMed Web of Science ®Google Scholar
• Ryan S. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol. 2017;595(8):2423–2430. doi:10.1113/JP273312
   PubMed Web of Science ®Google Scholar
• Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol. 2011;111(3):881–890. doi:10.1152/japplphysiol.00492.2011
   PubMed Web of Science ®Google Scholar
• Christen T, Sheikine Y, Rocha VZ, et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging. 2010;3(8):843–851. doi:10.1016/j.jcmg.2010.06.004
   PubMed Web of Science ®Google Scholar
• Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100(7):706–712. doi:10.1161/01.CIR.100.7.706
   PubMed Web of Science ®Google Scholar
• Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab. 2007;9(5):679–687. doi:10.1111/j.1463-1326.2006.00649.x
   Web of Science ®Google Scholar
• Hoyos CM, Killick R, Yee BJ, Phillips CL, Grunstein RR, Liu PY. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012;67(12):1081–1089. doi:10.1136/thoraxjnl-2011-201420
   Web of Science ®Google Scholar
• Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ. Meta-analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR, Adiponectin, and Visceral Adipose Fat. J Clin Sleep Med. 2015;11(4):475–485. doi:10.5664/jcsm.4610
   PubMed Web of Science ®Google Scholar
• Dekker SA, Noordam R, Biermasz NR, et al. Habitual sleep measures are associated with overall body fat, and not specifically with visceral fat, in men and women. Obesity. 2018;26(10):1651–1658. doi:10.1002/oby.22289
   Web of Science ®Google Scholar
• Kundel V, Trivieri MG, Karakatsanis NA, et al. Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath. 2018;22(4):1125–1135. doi:10.1007/s11325-018-1646-2
   Web of Science ®Google Scholar
• Drager LF, Brunoni AR, Jenner R, Lorenzi-Filho G, Bensenor IM, Lotufo PA. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax. 2015;70(3):258–264. doi:10.1136/thoraxjnl-2014-205361
   PubMed Web of Science ®Google Scholar
• Tachikawa R, Ikeda K, Minami T, et al. Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med. 2016;194(6):729–738. doi:10.1164/rccm.201511-2314OC
   Web of Science ®Google Scholar
• McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–931. doi:10.1056/NEJMoa1606599
   PubMed Web of Science ®Google Scholar